Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹317 Cr₹261 Cr₹237 Cr₹60 Cr₹189 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹317 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr
Mar2021₹189 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹317 Cr
21.52
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr
-68.11
Mar2021 ₹189 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,984.8 Cr 11.5% 8.3% 14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

11.5%

8.3%

14.8%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses